ArticleBreast cancer research and treatment2023

Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.

Taronish D Dubash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.